Bio Green Med Solution, Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Deerfield Special Situations Fund International LTD. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Deerfield Special Situations Fund International LTD har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
10% Owner 0
US:RIGL / Rigel Pharmaceuticals, Inc. 10% Owner 3.204.167
US:NURO / NeuroMetrix, Inc. 10% Owner 781.833
US:CYCC / Bio Green Med Solution, Inc. 10% Owner 881.743
US:DVAX / Dynavax Technologies Corporation 10% Owner 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Deerfield Special Situations Fund International LTD. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BGMS / Bio Green Med Solution, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BGMS / Bio Green Med Solution, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BGMS / Bio Green Med Solution, Inc. Insider Trades
Insidersalg BGMS / Bio Green Med Solution, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BGMS / Bio Green Med Solution, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2008-11-19 CYCC Flynn James E 71.200 0,2600 4.564 4,0560 18.512 104 6426 29.309.752 158.328,39
2008-11-19 CYCC Flynn James E 128.800 0,2600 8.256 4,0560 33.488
2008-11-19 CYCC Flynn James E 56.957 0,2400 3.651 3,7440 13.670
2008-11-19 CYCC Flynn James E 131.836 0,2400 8.451 3,7440 31.641
2008-11-18 CYCC Flynn James E 356 0,5600 23 8,7360 199
2008-11-18 CYCC Flynn James E 644 0,5600 41 8,7360 361
2008-11-18 CYCC Flynn James E 19.033 0,4400 1.220 6,8640 8.375
2008-11-18 CYCC Flynn James E 34.431 0,4400 2.207 6,8640 15.150
2008-11-14 CYCC Flynn James E 12.922 0,4900 828 7,6440 6.332
2008-11-14 CYCC Flynn James E 23.378 0,4900 1.499 7,6440 11.455
2008-11-13 CYCC Flynn James E 45.781 0,5000 2.935 7,8000 22.890
2008-11-13 CYCC Flynn James E 82.819 0,5000 5.309 7,8000 41.410
2008-11-13 CYCC Flynn James E 47.465 0,4800 3.043 7,4880 22.783
2008-11-13 CYCC Flynn James E 85.865 0,4800 5.504 7,4880 41.215

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BGMS / Bio Green Med Solution, Inc. Insider Trades
Insiderkøb RIGL / Rigel Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BGMS / Bio Green Med Solution, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2011-05-26 RIGL Flynn James E 46.524 8,0000 4.652 80,0000 372.192 253 104.8 115.338 30,99
2011-05-26 RIGL Flynn James E 72.800 8,0000 7.280 80,0000 582.400
2011-05-26 RIGL Flynn James E 229.252 8,0000 22.925 80,0000 1.834.016
2011-05-26 RIGL Flynn James E 301.424 8,0000 30.142 80,0000 2.411.392

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RIGL / Rigel Pharmaceuticals, Inc. Insider Trades
Insidersalg RIGL / Rigel Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BGMS / Bio Green Med Solution, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2010-11-03 RIGL Flynn James E 516 7,5500 52 75,5000 3.896 99 65.4 -560 -14,37
2010-11-03 RIGL Flynn James E 900 7,5500 90 75,5000 6.795
2010-11-03 RIGL Flynn James E 2.605 7,5500 260 75,5000 19.668
2010-11-03 RIGL Flynn James E 3.690 7,5500 369 75,5000 27.860

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

RIGL / Rigel Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Deerfield Special Situations Fund International LTD som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock Warrants (right to buy)
S - Sale -187.149 0 -100,00 0,38 -70.817
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock Warrants (right to buy)
S - Sale -116.172 0 -100,00 0,38 -43.959
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock Warrants (right to buy)
S - Sale -39.249 0 -100,00 0,38 -14.852
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock Warrants (right to buy)
S - Sale -21.414 0 -100,00 0,38 -8.103
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
C - Conversion -9.258 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
C - Conversion -5.748 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
C - Conversion -1.938 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
C - Conversion -1.056 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -19.620 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -12.179 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -4.114 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -2.243 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -21.213 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -13.168 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -4.448 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -2.426 0 -100,00
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -14.005.557 0 -100,00 0,06 -785.712
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 2.830.978 14.005.557 25,33 0,35 990.842 4.901.945
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 7.323.275 11.174.579 190,15 0,30 2.196.982 3.352.374
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 3.714.455 3.851.304 2.714,27 0,74 2.733.839 2.834.560
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -8.694.231 0 -100,00 0,06 -487.746
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 1.757.664 8.694.231 25,34 0,35 615.182 3.042.981
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 4.545.880 6.936.567 190,15 0,30 1.363.764 2.080.970
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 2.305.753 2.390.687 2.714,76 0,74 1.697.034 1.759.546
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -2.974.566 0 -100,00 0,06 -166.873
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 592.613 2.974.566 24,88 0,35 207.415 1.041.098
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 1.535.573 2.381.953 181,43 0,30 460.672 714.586
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 778.856 846.380 1.153,45 0,74 573.238 622.936
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -1.619.176 0 -100,00 0,06 -90.836
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 322.911 1.619.176 24,91 0,35 113.019 566.712
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 837.215 1.296.265 182,38 0,30 251.164 388.880
2013-07-18 2013-07-16 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
C - Conversion 424.798 459.050 1.240,21 0,74 312.651 337.861
2013-01-15 2013-01-11 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 3.086 9.258 50,00 100,00 308.600 925.800
2013-01-15 2013-01-11 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 1.916 5.748 50,00 100,00 191.600 574.800
2013-01-15 2013-01-11 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 646 1.938 50,00 100,00 64.600 193.800
2013-01-15 2013-01-11 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 352 1.056 50,00 100,00 35.200 105.600
2012-11-16 2012-11-14 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 1.543 6.172 33,33 100,00 154.300 617.200
2012-11-16 2012-11-14 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 958 3.832 33,33 100,00 95.800 383.200
2012-11-16 2012-11-14 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 323 1.292 33,33 100,00 32.300 129.200
2012-11-16 2012-11-14 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 176 704 33,33 100,00 17.600 70.400
2012-10-10 2012-09-28 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -3.510 0 -100,00
2012-10-10 2012-09-28 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -2.179 0 -100,00
2012-10-10 2012-09-28 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -736 0 -100,00
2012-10-10 2012-09-28 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -401 0 -100,00
2012-10-10 2012-09-28 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 3.510 19.620 21,79 100,00 351.000 1.962.000
2012-10-10 2012-09-28 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 2.179 12.179 21,79 100,00 217.900 1.217.900
2012-10-10 2012-09-28 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 736 4.114 21,79 100,00 73.600 411.400
2012-10-10 2012-09-28 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 401 2.243 21,77 100,00 40.100 224.300
2012-08-21 2012-08-17 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 3.086 4.629 200,00 100,00 308.600 462.900
2012-08-21 2012-08-17 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 1.916 2.874 200,00 100,00 191.600 287.400
2012-08-21 2012-08-17 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 646 969 200,00 100,00 64.600 96.900
2012-08-21 2012-08-17 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 352 528 200,00 100,00 35.200 52.800
2012-07-09 2012-07-05 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -228.392 136.849 -62,53 1,22 -278.638 166.956
2012-07-09 2012-07-05 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -141.750 84.934 -62,53 1,22 -172.935 103.619
2012-07-09 2012-07-05 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -112.693 67.524 -62,53 1,22 -137.485 82.379
2012-07-09 2012-07-05 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -57.165 34.252 -62,53 1,22 -69.741 41.787
2012-07-03 2012-07-03 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 1.543 1.543 100,00 154.300 154.300
2012-07-03 2012-07-03 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 958 958 100,00 95.800 95.800
2012-07-03 2012-07-03 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 323 323 100,00 32.300 32.300
2012-07-03 2012-07-03 4 TLON.OB Talon Therapeutics, Inc.
Series A-3 Convertible Preferred Stock
A - Award 176 176 100,00 17.600 17.600
2012-07-03 2012-07-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -283.180 299.811 -48,57 1,33 -376.629 398.749
2012-07-03 2012-07-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -175.782 186.037 -48,58 1,33 -233.790 247.429
2012-07-03 2012-07-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -59.388 252.561 -19,04 1,33 -78.986 335.906
2012-07-03 2012-07-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -32.402 125.150 -20,57 1,33 -43.095 166.450
2012-07-03 2012-07-02 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -85.623 582.991 -12,81 1,20 -102.748 699.589
2012-07-03 2012-07-02 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -53.150 361.819 -12,81 1,20 -63.780 434.183
2012-07-03 2012-07-02 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -17.957 311.949 -5,44 1,20 -21.548 374.339
2012-07-03 2012-07-02 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -9.797 157.552 -5,85 1,20 -11.756 189.062
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -3.472 1 -99,97
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -2.155 1 -99,95
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -728 1 -99,86
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -397 1 -99,75
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 3.472 16.110 27,47 100,00 347.200 1.611.000
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 2.155 10.000 27,47 100,00 215.500 1.000.000
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 728 3.378 27,47 100,00 72.800 337.800
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 397 1.842 27,47 100,00 39.700 184.200
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -82.321 668.614 -10,96 1,14 -93.846 762.220
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -51.091 414.969 -10,96 1,14 -58.244 473.065
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -40.619 329.906 -10,96 1,14 -46.306 376.093
2012-07-03 2012-06-29 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -20.604 167.349 -10,96 1,14 -23.489 190.778
2012-06-28 2012-06-28 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -92.964 750.935 -11,02 1,07 -99.471 803.500
2012-06-28 2012-06-28 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -57.697 466.060 -11,02 1,07 -61.736 498.684
2012-06-28 2012-06-28 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -45.871 370.525 -11,02 1,07 -49.082 396.462
2012-06-28 2012-06-28 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -23.268 187.953 -11,02 1,07 -24.897 201.110
2012-06-28 2012-06-27 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -49.170 843.899 -5,51 1,00 -49.170 843.899
2012-06-28 2012-06-27 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -30.517 523.757 -5,51 1,00 -30.517 523.757
2012-06-28 2012-06-27 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -24.262 416.396 -5,51 1,00 -24.262 416.396
2012-06-28 2012-06-27 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -12.307 211.221 -5,51 1,00 -12.307 211.221
2012-06-28 2012-06-26 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -26.357 893.069 -2,87 0,98 -25.830 875.208
2012-06-28 2012-06-26 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -16.358 554.274 -2,87 0,98 -16.031 543.189
2012-06-28 2012-06-26 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -13.005 440.658 -2,87 0,98 -12.745 431.845
2012-06-28 2012-06-26 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -6.597 223.528 -2,87 0,98 -6.465 219.057
2012-05-07 2012-05-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -27.500 919.426 -2,90 0,98 -26.950 901.037
2012-05-07 2012-05-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -70.184 946.926 -6,90 0,99 -69.482 937.457
2012-05-07 2012-05-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -17.123 570.632 -2,91 0,98 -16.781 559.219
2012-05-07 2012-05-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -43.600 587.755 -6,91 0,99 -43.164 581.877
2012-05-07 2012-05-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -11.900 453.663 -2,56 0,98 -11.662 444.590
2012-05-07 2012-05-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -30.400 465.563 -6,13 0,99 -30.096 460.907
2012-05-07 2012-05-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -8.577 230.125 -3,59 0,98 -8.405 225.522
2012-05-07 2012-05-03 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -21.816 238.702 -8,37 0,99 -21.598 236.315
2012-05-07 2012-03-31 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -3.472 1 -99,97
2012-05-07 2012-03-31 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -2.155 1 -99,95
2012-05-07 2012-03-31 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -728 1 -99,86
2012-05-07 2012-03-31 4 TLON.OB Talon Therapeutics, Inc.
Right to acquire Series A-2 Convertible Preferred Stock
C - Conversion -397 1 -99,75
2012-05-07 2012-03-31 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 3.472 12.638 37,88 100,00 347.200 1.263.800
2012-05-07 2012-03-31 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 2.155 7.845 37,87 100,00 215.500 784.500
2012-05-07 2012-03-31 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 728 2.650 37,88 100,00 72.800 265.000
2012-05-07 2012-03-31 4 TLON.OB Talon Therapeutics, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion 397 1.445 37,88 100,00 39.700 144.500
2012-03-23 2012-03-21 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -48.600 1.017.110 -4,56 1,05 -51.030 1.067.966
2012-03-23 2012-03-21 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -30.226 631.355 -4,57 1,05 -31.737 662.923
2012-03-23 2012-03-21 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -21.074 495.963 -4,08 1,05 -22.128 520.761
2012-03-23 2012-03-21 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -15.100 260.518 -5,48 1,05 -15.855 273.544
2012-03-14 2012-03-14 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -15.025 1.065.710 -1,39 1,01 -15.175 1.076.367
2012-03-14 2012-03-14 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -9.326 661.581 -1,39 1,01 -9.419 668.197
2012-03-14 2012-03-14 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -7.290 517.037 -1,39 1,01 -7.363 522.207
2012-03-14 2012-03-14 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -3.885 275.618 -1,39 1,01 -3.924 278.374
2012-03-14 2012-03-13 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -7.824 1.080.735 -0,72 1,04 -8.137 1.123.964
2012-03-14 2012-03-13 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -4.857 670.907 -0,72 1,04 -5.051 697.743
2012-03-14 2012-03-13 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -3.796 524.327 -0,72 1,04 -3.948 545.300
2012-03-14 2012-03-13 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -2.023 279.503 -0,72 1,04 -2.104 290.683
2012-03-14 2012-03-12 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -52.094 1.088.559 -4,57 1,11 -57.824 1.208.300
2012-03-14 2012-03-12 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -32.339 675.764 -4,57 1,11 -35.896 750.098
2012-03-14 2012-03-12 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -25.275 528.123 -4,57 1,11 -28.055 586.217
2012-03-14 2012-03-12 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -13.472 281.526 -4,57 1,11 -14.954 312.494
2012-03-12 2012-03-09 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -64.706 1.140.653 -5,37 1,20 -77.647 1.368.784
2012-03-12 2012-03-09 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -40.167 708.103 -5,37 1,20 -48.200 849.724
2012-03-12 2012-03-09 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -31.393 553.398 -5,37 1,20 -37.672 664.078
2012-03-12 2012-03-09 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -16.734 294.998 -5,37 1,20 -20.081 353.998
2012-03-12 2012-03-08 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -23.261 1.205.359 -1,89 1,04 -24.191 1.253.573
2012-03-12 2012-03-08 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -14.439 748.270 -1,89 1,04 -15.017 778.201
2012-03-12 2012-03-08 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -11.285 584.791 -1,89 1,04 -11.736 608.183
2012-03-12 2012-03-08 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -6.015 311.732 -1,89 1,04 -6.256 324.201
2012-03-12 2012-03-07 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -8.881 1.228.620 -0,72 0,99 -8.792 1.216.334
2012-03-12 2012-03-07 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -5.513 762.709 -0,72 0,99 -5.458 755.082
2012-03-12 2012-03-07 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -4.310 596.076 -0,72 0,99 -4.267 590.115
2012-03-12 2012-03-07 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -2.296 317.747 -0,72 0,99 -2.273 314.570
2012-02-08 2012-02-06 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -10.600 1.237.501 -0,85 0,98 -10.388 1.212.751
2012-02-08 2012-02-06 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -6.536 768.222 -0,84 0,98 -6.405 752.858
2012-02-08 2012-02-06 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -4.564 600.386 -0,75 0,98 -4.473 588.378
2012-02-08 2012-02-06 4 TLON.OB Talon Therapeutics, Inc.
Common Stock
S - Sale -3.300 320.043 -1,02 0,98 -3.234 313.642
2011-06-07 2011-05-26 4 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
P - Purchase 301.424 3.204.167 10,38 8,00 2.411.392 25.633.336
2011-06-07 2011-05-26 4 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
P - Purchase 229.252 2.279.997 11,18 8,00 1.834.016 18.239.976
2011-06-07 2011-05-26 4 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
P - Purchase 72.800 762.700 10,55 8,00 582.400 6.101.600
2011-06-07 2011-05-26 4 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
P - Purchase 46.524 470.425 10,98 8,00 372.192 3.763.400
2010-12-14 2010-12-14 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -11.557 781.833 -1,46 0,51 -5.894 398.735
2010-12-14 2010-12-14 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -6.443 435.887 -1,46 0,51 -3.286 222.302
2010-12-14 2010-12-14 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -8.925 793.390 -1,11 0,50 -4.462 396.695
2010-12-14 2010-12-14 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -4.975 442.330 -1,11 0,50 -2.488 221.165
2010-12-14 2010-12-14 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -192.615 802.315 -19,36 0,51 -98.234 409.181
2010-12-14 2010-12-14 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -107.385 447.305 -19,36 0,51 -54.766 228.126
2010-11-18 2010-11-18 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -20.995 994.930 -2,07 0,58 -12.177 577.059
2010-11-18 2010-11-18 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -11.705 554.690 -2,07 0,58 -6.789 321.720
2010-11-18 2010-11-18 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -88.905 1.015.925 -8,05 0,56 -49.787 568.918
2010-11-18 2010-11-18 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -49.565 566.395 -8,05 0,56 -27.756 317.181
2010-11-18 2010-11-18 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -290.692 1.104.830 -20,83 0,60 -174.415 662.898
2010-11-18 2010-11-18 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -162.064 615.960 -20,83 0,60 -97.238 369.576
2010-11-18 2010-11-17 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -1.011 1.395.522 -0,07 0,55 -556 767.537
2010-11-18 2010-11-17 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -563 778.024 -0,07 0,55 -310 427.913
2010-11-18 2010-11-17 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -128.003 1.396.533 -8,40 0,56 -71.682 782.058
2010-11-18 2010-11-17 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -71.362 778.587 -8,40 0,56 -39.963 436.009
2010-11-18 2010-11-17 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -10.209 1.524.536 -0,67 0,53 -5.411 808.004
2010-11-18 2010-11-17 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -5.691 849.949 -0,67 0,53 -3.016 450.473
2010-11-18 2010-11-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -193 1.534.745 -0,01 0,59 -114 905.500
2010-11-18 2010-11-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -107 855.640 -0,01 0,59 -63 504.828
2010-11-18 2010-11-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -34.724 1.534.938 -2,21 0,58 -20.140 890.264
2010-11-18 2010-11-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -19.358 855.747 -2,21 0,58 -11.228 496.333
2010-11-18 2010-11-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -4.816 1.569.662 -0,31 0,58 -2.793 910.404
2010-11-18 2010-11-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -2.684 875.105 -0,31 0,58 -1.557 507.561
2010-11-05 2010-11-03 4 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
S - Sale -3.690 2.902.743 -0,13 7,55 -27.860 21.915.710
2010-11-05 2010-11-03 4 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
S - Sale -2.605 2.050.745 -0,13 7,55 -19.668 15.483.125
2010-11-05 2010-11-03 4 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
S - Sale -900 689.900 -0,13 7,55 -6.795 5.208.745
2010-11-05 2010-11-03 4 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
S - Sale -516 423.901 -0,12 7,55 -3.896 3.200.453
2010-11-05 3 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
2.053.350
2010-11-05 3 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
2.906.433
2010-11-05 3 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
424.417
2010-11-05 3 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
690.800
2010-11-05 3 RIGL RIGEL PHARMACEUTICALS INC
Common Stock
25.000
2010-10-28 2010-10-26 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -63.563 1.574.478 -3,88 0,59 -37.502 928.942
2010-10-28 2010-10-26 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -35.437 877.789 -3,88 0,59 -20.908 517.896
2010-09-28 2010-09-27 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -129 1.638.041 -0,01 0,58 -75 950.064
2010-09-28 2010-09-27 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -71 913.226 -0,01 0,58 -41 529.671
2010-09-28 2010-09-24 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -12.842 1.638.170 -0,78 0,58 -7.448 950.139
2010-09-28 2010-09-24 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -7.158 913.297 -0,78 0,58 -4.152 529.712
2010-09-23 2010-09-23 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -1.443 1.651.012 -0,09 0,59 -851 974.097
2010-09-23 2010-09-23 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -804 920.455 -0,09 0,59 -474 543.068
2010-09-23 2010-09-22 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -2 1.652.455 0,00 0,58 -1 958.424
2010-09-23 2010-09-21 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -28.553 1.652.457 -1,70 0,59 -16.846 974.950
2010-09-23 2010-09-21 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -15.917 921.259 -1,70 0,59 -9.391 543.543
2010-09-23 2010-09-21 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -4.559 1.681.010 -0,27 0,58 -2.644 974.986
2010-09-23 2010-09-21 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -2.541 937.176 -0,27 0,58 -1.474 543.562
2010-09-17 2010-09-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -192.616 1.685.569 -10,26 0,58 -111.717 977.630
2010-09-17 2010-09-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -107.384 939.717 -10,26 0,58 -62.283 545.036
2010-09-17 2010-09-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -256.821 1.878.185 -12,03 0,59 -151.524 1.108.129
2010-09-17 2010-09-16 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -143.179 1.047.101 -12,03 0,59 -84.476 617.790
2010-09-17 2010-09-15 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -40.129 2.135.006 -1,84 0,60 -24.077 1.281.004
2010-09-17 2010-09-15 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -22.371 1.190.280 -1,84 0,60 -13.423 714.168
2010-08-23 2010-08-19 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -3.780 2.175.135 -0,17 0,89 -3.364 1.935.870
2010-08-23 2010-08-19 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -2.107 1.212.651 -0,17 0,89 -1.875 1.079.259
2010-08-23 2010-08-19 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -642.053 2.178.915 -22,76 0,78 -500.801 1.699.554
2010-08-23 2010-08-19 4 NURO NeuroMetrix, Inc.
Common Stock
S - Sale -357.947 1.214.758 -22,76 0,78 -279.199 947.511
2009-09-11 2009-09-09 4 NURO NeuroMetrix, Inc.
Common Stock Warrants (right to buy)
P - Purchase 1.544.750 1.544.750 0,12 193.094 193.094
2009-09-11 2009-09-09 4 NURO NeuroMetrix, Inc.
Common Stock Warrants (right to buy)
P - Purchase 876.489 876.489 0,12 109.561 109.561
2009-09-11 2009-09-09 4 NURO NeuroMetrix, Inc.
Common Stock
P - Purchase 1.626.053 2.820.968 136,08 2,00 3.252.106 5.641.936
2009-09-11 2009-09-09 4 NURO NeuroMetrix, Inc.
Common Stock
P - Purchase 922.620 1.572.705 141,92 2,00 1.845.240 3.145.410
2008-12-05 3 NURO NeuroMetrix, Inc.
Common Stock
650.085
2008-12-05 3 NURO NeuroMetrix, Inc.
Common Stock
1.194.915
2008-11-20 2008-11-19 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -131.836 881.743 -13,01 0,24 -31.641 211.618
2008-11-20 2008-11-19 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -56.957 503.348 -10,17 0,24 -13.670 120.804
2008-11-20 2008-11-19 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -128.800 1.013.579 -11,27 0,26 -33.488 263.531
2008-11-20 2008-11-19 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -71.200 560.305 -11,27 0,26 -18.512 145.679
2008-11-20 2008-11-18 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -34.431 1.142.379 -2,93 0,44 -15.150 502.647
2008-11-20 2008-11-18 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -19.033 631.505 -2,93 0,44 -8.375 277.862
2008-11-20 2008-11-18 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -644 1.176.810 -0,05 0,56 -361 659.014
2008-11-20 2008-11-18 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -356 650.538 -0,05 0,56 -199 364.301
2008-11-14 2008-11-14 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -23.378 1.177.454 -1,95 0,49 -11.455 576.952
2008-11-14 2008-11-14 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -12.922 650.894 -1,95 0,49 -6.332 318.938
2008-11-14 2008-11-13 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -85.865 1.200.832 -6,67 0,48 -41.215 576.399
2008-11-14 2008-11-13 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -47.465 663.816 -6,67 0,48 -22.783 318.632
2008-11-14 2008-11-13 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -82.819 1.286.697 -6,05 0,50 -41.410 643.348
2008-11-14 2008-11-13 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
S - Sale -45.781 711.281 -6,05 0,50 -22.890 355.640
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -276.493 0 -100,00 0,24 -66.358
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -56.742 276.493 -17,03 0,22 -12.636 61.575
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -533.176 333.235 -61,54 0,27 -141.771 88.607
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -138.370 0 -100,00 0,24 -33.209
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -28.395 138.370 -17,03 0,22 -6.324 30.815
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -266.824 166.765 -61,54 0,27 -70.949 44.343
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -195.563 0 -100,00 0,24 -47.228
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -225.156 195.563 -53,52 0,23 -50.930 44.236
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -317.000 420.719 -42,97 0,24 -75.858 100.678
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -41.123 737.719 -5,28 0,23 -9.339 167.536
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -95.100 778.842 -10,88 0,28 -26.580 217.686
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -63.400 873.942 -6,76 0,25 -15.850 218.486
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -96.075 937.342 -9,30 0,25 -23.961 233.773
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -1.001.720 1.033.417 -49,22 0,26 -257.342 265.485
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -125.000 0 -100,00 0,24 -30.625
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -329.437 125.000 -72,49 0,24 -79.559 30.188
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -129.981 454.437 -22,24 0,23 -29.402 102.794
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -183.000 584.418 -23,85 0,24 -43.792 139.851
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -23.740 767.418 -3,00 0,23 -5.391 174.281
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -54.900 791.158 -6,49 0,28 -15.345 221.129
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -36.600 846.058 -4,15 0,25 -9.150 211.514
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -55.463 882.658 -5,91 0,25 -13.832 220.135
2008-10-24 2008-10-22 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
S - Sale -578.280 938.121 -38,14 0,26 -148.560 241.003
2008-06-30 2007-12-27 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 105.300 105.300
2008-06-30 2007-12-27 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 61.300 61.300
2008-06-30 2007-12-27 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 519.200 519.200
2008-06-30 2007-12-27 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 314.200 314.200
2008-03-14 3 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
757.062
2008-03-14 3 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
1.369.516
2007-11-01 2007-10-18 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 136.890 136.890
2007-11-01 2007-10-18 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 79.960 79.960
2007-11-01 2007-10-18 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 674.960 674.960
2007-11-01 2007-10-18 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 408.460 408.460
2007-07-23 2007-07-18 4/A DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 131.625 131.625
2007-07-23 2007-07-18 4/A DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 76.625 76.625
2007-07-23 2007-07-18 4/A DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 649.000 649.000
2007-07-23 2007-07-18 4/A DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 392.750 392.750
2007-07-20 2007-07-18 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 131.625 131.625
2007-07-20 2007-07-18 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 76.625 76.625
2007-07-20 2007-07-18 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 649.000 649.000
2007-07-20 2007-07-18 4 DVAX DYNAVAX TECHNOLOGIES CORP
Warrants
P - Purchase 392.750 392.750
2006-10-06 2006-10-04 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 376.185 2.035.137 22,68 4,40 1.655.214 8.954.603
2006-10-06 2006-10-04 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 257.122 1.516.401 20,42 4,40 1.131.337 6.672.164
2006-10-06 2006-10-04 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 105.142 433.589 32,01 4,40 462.625 1.907.792
2006-10-06 2006-10-04 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 211.551 866.411 32,30 4,40 930.824 3.812.208
2006-05-17 2006-05-15 4/A DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 24.100 328.447 7,92 5,50 132.543 1.806.360
2006-05-15 2006-05-15 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 24.100 327.447 7,94 5,50 132.543 1.800.860
2006-05-15 2006-05-15 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 63.565 654.860 10,75 5,50 349.588 3.601.534
2006-05-15 2006-05-12 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 10.246 591.295 1,76 5,50 56.345 3.251.649
2006-05-15 2006-05-11 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 3.226 581.049 0,56 5,12 16.501 2.972.066
2006-05-15 2006-05-11 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 1.602 304.347 0,53 5,12 8.194 1.556.735
2006-05-02 2006-05-01 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 11.200 577.823 1,98 5,71 63.945 3.299.023
2006-05-02 2006-05-01 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 200 302.745 0,07 5,71 1.142 1.728.492
2006-05-02 2006-04-28 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 5.211 566.623 0,93 5,72 29.785 3.238.704
2006-05-02 2006-04-28 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 2.589 302.545 0,86 5,72 14.798 1.729.287
2006-05-02 2006-04-28 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 28.701 1.658.952 1,76 5,50 157.856 9.124.236
2006-05-02 2006-04-28 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 21.299 1.259.279 1,72 5,50 117.144 6.926.034
2006-04-24 2006-04-05 4/A DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 1.549 540.673 0,29 6,02 9.319 3.252.851
2006-04-24 2006-04-05 4/A DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 768 289.650 0,27 6,02 4.621 1.742.621
2006-04-24 2006-04-05 4/A DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 13.180 1.566.513 0,85 6,02 79.295 9.424.612
2006-04-24 2006-04-05 4/A DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 9.779 1.190.678 0,83 6,02 58.833 7.163.476
2006-04-24 2006-04-24 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 12.065 561.412 2,20 5,55 66.964 3.116.005
2006-04-24 2006-04-24 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 5.996 299.956 2,04 5,55 33.280 1.664.846
2006-04-24 2006-04-24 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 31.102 1.630.251 1,94 5,55 172.625 9.048.382
2006-04-24 2006-04-24 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 23.082 1.237.980 1,90 5,55 128.112 6.871.160
2006-04-24 2006-04-21 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 6.680 549.347 1,23 5,43 36.297 2.984.987
2006-04-24 2006-04-21 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 3.320 293.960 1,14 5,43 18.040 1.597.290
2006-04-24 2006-04-21 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 17.220 1.599.149 1,09 5,43 93.568 8.689.296
2006-04-24 2006-04-21 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 12.780 1.214.898 1,06 5,43 69.443 6.601.391
2006-04-24 2006-04-20 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 1.994 542.667 0,37 5,48 10.923 2.972.784
2006-04-24 2006-04-20 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 990 290.640 0,34 5,48 5.423 1.592.155
2006-04-24 2006-04-20 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 15.416 1.581.929 0,98 5,48 84.450 8.665.965
2006-04-24 2006-04-20 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 11.440 1.202.118 0,96 5,48 62.669 6.585.323
2006-04-05 2006-04-05 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 13.180 552.304 2,44 6,02 79.295 3.322.827
2006-04-05 2006-04-05 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 9.779 298.661 3,39 6,02 58.833 1.796.834
2006-04-05 2006-04-05 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 1.549 1.554.882 0,10 6,02 9.319 9.354.637
2006-04-05 2006-04-05 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 768 1.181.667 0,07 6,02 4.621 7.109.263
2006-04-05 2006-04-04 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 1.761 539.124 0,33 6,03 10.626 3.253.182
2006-04-05 2006-04-04 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 874 288.882 0,30 6,03 5.274 1.743.172
2006-04-05 2006-04-04 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 26.678 1.553.333 1,75 6,03 160.980 9.373.122
2006-04-05 2006-04-04 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 19.796 1.180.899 1,70 6,03 119.453 7.125.781
2006-04-05 2006-04-03 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 32.132 537.363 6,36 6,03 193.804 3.241.105
2006-04-05 2006-04-03 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 15.968 288.008 5,87 6,03 96.311 1.737.120
2006-03-17 2006-03-17 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 1.122 505.231 0,22 5,91 6.630 2.985.663
2006-03-17 2006-03-17 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 603 272.040 0,22 5,91 3.563 1.607.620
2006-03-17 2006-03-17 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 7.248 1.526.655 0,48 5,91 42.832 9.021.768
2006-03-17 2006-03-17 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 5.511 1.161.103 0,48 5,91 32.567 6.861.538
2006-03-17 2006-03-16 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 2.938 504.109 0,59 6,02 17.694 3.035.946
2006-03-17 2006-03-16 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 1.581 271.437 0,59 6,02 9.521 1.634.702
2006-03-17 2006-03-16 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 18.981 1.519.407 1,27 6,02 114.311 9.150.477
2006-03-17 2006-03-16 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 14.434 1.155.592 1,26 6,02 86.927 6.959.437
2006-03-17 2006-03-15 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 5.281 501.171 1,06 5,95 31.439 2.983.621
2006-03-17 2006-03-15 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 2.843 269.856 1,06 5,95 16.925 1.606.534
2006-03-17 2006-03-15 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 34.119 1.500.426 2,33 5,95 203.121 8.932.486
2006-03-17 2006-03-15 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 25.948 1.141.158 2,33 5,95 154.476 6.793.656
2006-03-09 2006-03-09 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 1.185 495.890 0,24 6,03 7.144 2.989.423
2006-03-09 2006-03-09 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 638 267.013 0,24 6,03 3.846 1.609.661
2006-03-09 2006-03-09 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 7.655 1.466.307 0,52 6,03 46.147 8.839.485
2006-03-09 2006-03-09 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 5.822 1.115.210 0,52 6,03 35.097 6.722.932
2006-03-09 2006-03-07 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 11.375 494.705 2,35 6,00 68.250 2.968.230
2006-03-09 2006-03-07 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 6.125 266.375 2,35 6,00 36.750 1.598.250
2006-03-07 2006-03-03 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 9.840 483.330 2,08 5,90 58.068 2.852.227
2006-03-07 2006-03-03 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 5.295 260.250 2,08 5,90 31.247 1.535.787
2006-03-07 2006-03-03 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 59.128 1.458.652 4,22 5,90 348.926 8.607.797
2006-03-07 2006-03-03 4 DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
P - Purchase 44.967 1.109.388 4,22 5,90 265.359 6.546.720
2006-03-07 3/A DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
993.599
2006-03-07 3/A DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
245.000
2006-03-07 3/A DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
1.306.401
2006-03-07 3/A DVAX DYNAVAX TECHNOLOGIES CORP
Common Stock
455.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)